4.8 Review

Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets

Journal

JOURNAL OF HEPATOLOGY
Volume 67, Issue 3, Pages 603-618

Publisher

ELSEVIER
DOI: 10.1016/j.jhep.2017.04.009

Keywords

Hepatocellular carcinoma; HCC; Long non; coding RNA; lncRNA; microRNA; Liver cancer; STAT3; Wnt; Epithelial-to-mesenchymal transition; Cancer stem cell

Funding

  1. Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)
  2. Deutsche Forschungsgemeinschaft [DFG Di 1421/7-1, EXC81, SFB 850]
  3. Office of the NIH Director Common Fund Program through the National Center for Advancing Translational Sciences [UH3 TR00884]

Ask authors/readers for more resources

The majority of the human genome is not translated into proteins but can be transcribed into RNA. Even though the resulting non-coding RNAs (ncRNAs) do not encode for proteins, they contribute to diseases such as cancer. Here, we review examples of the functions of ncRNAs in liver cancer and their potential use for the detection and treatment of liver cancer. (C) 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available